老年人的瘤病毒治疗:免疫脆弱,挑战和前景
Jia-Wen Wang1, Jia-Hui Liu1, Yue-Lin Liu2
1Department of Orthopedics, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
Frontiers in immunology
|October 24, 2025
概括
人口老龄化面临着不断上升的癌症率和独特的免疫挑战. 瘤病毒 (OVs) 是有前途的,但老年患者,尤其是脆弱的患者,需要量身定制的治疗来管理免疫风险并改善结果.
科学领域:
- 老年学是指老年学的学科.
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- 全球老龄化增加了65岁以上成年人癌症发病率,他们占大多数癌症病例和死亡人数.
- 年长的成年人有明显的免疫失衡 (免疫抑制,免疫发生,炎症) 影响治疗耐受性和疗效,特别是PD-1/PD-L1抑制剂.
- 根据G8评分评估的与年龄相关的脆弱性,可以加剧接受癌症治疗的老年患者的免疫脆弱性.
研究的目的:
- 审查癌症患者衰老的免疫特征.
- 强调需要解决脆弱老年人群中与年龄相关的免疫脆弱性的需要.
- 在老年癌症患者中概述瘤病毒 (OV) 治疗的挑战和未来方向.
主要方法:
- 文献综述专注于衰老,癌症,免疫学和结性病毒疗法.
- 对癌症老年人免疫失调的分析.
- 对瘤性病毒机制和老年人群的临床数据的检查.
主要成果:
- 瘤病毒 (OVs) 选择性地向瘤细胞,诱导免疫细胞死亡,并激活cGAS-STING通路,显示出潜在的抗瘤作用.
- 在黑色素瘤/肉瘤亚组中观察到有希望的结果 (例如,26.4-32.9%的ORR),但对其他癌症的老年患者的数据有限.
- 老年患者,特别是脆弱的患者,由于与年龄相关的免疫脆弱性,在OV治疗时可能面临更高的免疫过载和细胞因子风暴的风险.
结论:
- 瘤消毒病毒疗法有可能治疗老年人癌症.
- 定制OV策略以考虑与年龄相关的免疫脆弱性和脆弱性对于优化疗效和安全至关重要.
- 需要进行进一步的系统研究,以评估不同老年癌症患者群体的OV疗效和耐受性,并考虑脆弱性评估.
更多相关视频
相关概念视频
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
185
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
185
01:26Aging
587
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
587
01:27Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
02:56Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
02:49Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
195
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
195